Novo Nordisk A/S (NYSE:NVO)

47.75
Delayed Data
As of Feb 27
 +0.22 / +0.46%
Today’s Change
41.72
Today|||52-Week Range
49.11
+12.83%
Year-to-Date

Today’s Trading

Previous close47.53
Today’s open47.40
Day’s range47.35 - 48.03
Volume1,046,418
Average volume (3 months)1,367,063
Market cap$97.9B
Dividend yield1.59%
Data as of 4:04pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+5.60%
P/E ratio4.7
Price/Sales7.05
Price/Book18.91

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-1.82-1.48%
ABBVAbbVie-0.02-0.03%
BMYBristol-Myers Squibb-0.54-0.88%
AZNAstraZeneca-0.11-0.16%
Data as of 4:07pm ET, 02/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.47
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account